Done Global: Operational viability and defense against DOJ corporate criminal indictment for telehealth fraud 2025-2026

The Department of Justice has launched an crackdown on telehealth fraud. Done Global faces a corporate criminal indictment following the November 2025 convictions of its top executives. This investigation answers 20 serious questions regarding the operational viability of the company.

1. What is the core charge? Conspiracy to distribute controlled substances.
2. Who was convicted? Founder Ruthia He and clinical president David Brody.
3. When were they convicted? November 19, 2025.
4. What is the corporate indictment date? December 17, 2025.
5. How much revenue was generated? Over $100 million.
6. How pills were prescribed? Over 40 million.
7. What was the advertising budget? $40 million.
8. Which shell company was used? Mindful Mental Wellness.
9. Where was the shell company located? Florida.
10. What was the obstruction charge? Deleting documents and using encrypted messaging.
11. Where did Ruthia He attempt to relocate? China.
12. How much money was transferred to China? $1 million.
13. What is the maximum prison sentence? 20 years.
14. When is the sentencing date? February 25, 2026.
15. Which federal programs were defrauded? Medicare and Medicaid.
16. What law governs online prescribing? The Ryan Haight Act.
17. Did the company require video visits? Sometimes no video or audio was used.
18. What is the corporate penalty risk? Twice the gross profits.
19. Which agency led the investigation? The Drug Enforcement Administration.
20. the company survive? Operational viability is severely compromised.

The federal government secured guilty verdicts against Done Global founder Ruthia He and clinical president David Brody on November 19, 2025. A jury in San Francisco convicted both executives of conspiracy to distribute controlled substances and conspiracy to commit health care fraud. The Department of Justice documented that the executives arranged for the prescription of over 40 million pills of Adderall and other stimulants. The operation generated over $100 million in revenue. The executives spent $40 million on social media advertisements to attract patients.

The Department of Justice escalated the legal proceedings on December 17, 2025. A federal grand jury returned a corporate criminal indictment against Done Global and a Florida medical practice named Mindful Mental Wellness. Prosecutors state that Done Global incorporated Mindful Mental Wellness to bypass pharmacies that blocked prescriptions from Done Global providers. The corporate indictment charges Done Global with conspiracy to illegally distribute Adderall and conspiracy to commit health care fraud. The company faces a maximum penalty of twice the gross profits or other proceeds.

The operational viability of Done Global is severely compromised. The company relied on a subscription model. Patients paid a monthly fee to access prescribers. The Department of Justice proved that the company instructed prescribers to write stimulant prescriptions without a legitimate medical purpose. The company compensated providers based on the volume of pills prescribed rather than the quality of medical consultations. The government presented evidence that patients received prescriptions after short video or audio communications. Patients frequently received prescriptions without any video or audio communication.

The obstruction of justice conviction against Ruthia He details deliberate attempts to evade law enforcement. The executive moved company operations to China after learning of the federal investigation. She transferred $1 million to a Chinese shell company named Make Believe Asia. She deleted incriminatory documents and used encrypted messaging applications with disappearing messages. Law enforcement intercepted her in San Francisco as she prepared to leave the United States.

The financial impact on federal health care programs is substantial. Medicare and Medicaid paid over $14 million based on false prior authorization requests. Done Global claimed that its providers followed standard diagnostic criteria and used urine drug screens. The company falsely stated that patients had tried nonstimulant medications without success. The corporate indictment accuses the company of continuing to submit false claims to commercial insurers.

The Drug Enforcement Administration led the investigation alongside the Department of Health and Human Services Office of Inspector General. The agencies identified the operation as a mass production stimulant mill. The business model prioritized addiction and deception over patient safety. The corporate indictment signals a shift in federal enforcement strategy. The Department of Justice the corporate entities that illegal drug distribution through digital platforms.

The court scheduled the sentencing for Ruthia He and David Brody following their November 2025 convictions. Both executives face a maximum penalty of 20 years in prison. The corporate entity must defend against identical charges. The use of Mindful Mental Wellness to circumvent pharmacy blocks demonstrates a coordinated effort to maintain the flow of controlled substances. The operational structure of Done Global cannot survive the current legal and financial penalties. The company faces the loss of its prescribing network and the seizure of its assets.

A federal jury in the Northern District of California delivered a guilty verdict on November 19, 2025. Ruthia He and David Brody were convicted of conspiracy to distribute controlled substances and conspiracy to commit health care fraud. Ruthia He received an additional conviction for conspiracy to obstruct justice. The Department of Justice labeled this the of its kind criminal drug distribution prosecution tied to a digital health telemedicine prescribing model. The verdict establishes a lethal precedent for the operational future of Done Global.

Senior United States District Judge Charles Breyer presided over the trial. The jury evaluated evidence demonstrating that the executives built a business model reliant on the mass distribution of Adderall. Prosecutors proved that Done Global spent 40 million dollars on targeted social media advertisements. These campaigns specifically sought out individuals searching for stimulants. The company directed medical providers to limit initial patient consultations to under 30 minutes. This duration is half the standard time required for a proper psychiatric evaluation. The executives paid nurse practitioners up to 60, 000 dollars per month. These payments rewarded providers for approving prescription refills without conducting follow up appointments.

Trial testimony exposed the internal directives issued by the leadership team. Ruthia He told employees that successful technology companies profit off addiction. She offered a luxury electric car to staff members who broke the law to increase prescription volume. David Brody instructed nurses to continue prescribing stimulants to patients showing clear signs of medication abuse. He told his clinical staff to disregard the risk of going to jail. The executives implemented an automatic refill policy that removed clinical oversight from the prescribing process. They prioritized subscription revenue over medical need.

The financial metrics presented in court quantify the size of the operation. Done Global generated 100 million dollars in revenue through its subscription model. The company arranged for the distribution of 40 million stimulant pills. The executives also defrauded Medicare, Medicaid, and commercial insurers. The jury found that the company submitted false prior authorization requests. The executives falsely claimed that Done Global followed standard diagnostic criteria, used urine drug screens, and tried non stimulant medications. This specific insurance fraud cost taxpayers and private insurers 14 million dollars.

The obstruction of justice conviction against Ruthia He from her actions following a grand jury subpoena. She directed employees to delete internal documents. She mandated the use of encrypted messaging applications with disappearing messages to conceal communications from federal investigators. Trial evidence showed she moved operations to China to hide evidence. She transferred over one million dollars to a Chinese shell company named Make Believe Asia. She conducted internet searches for countries that did not have extradition treaties with the United States. The jury determined these actions constituted a deliberate attempt to impede the federal inquiry.

The Department of Justice Criminal Division Health Care Fraud Unit used these convictions to escalate their enforcement actions. On December 17, 2025, a federal grand jury returned a superseding indictment against the corporate entity Done Global and its affiliated medical practice Mindful Mental Wellness. The corporate indictment details how the executives attempted to bypass regulatory safeguards. Pharmacies began blocking prescriptions originating from Done Global providers. The executives incorporated Mindful Mental Wellness in Florida to circumvent these pharmacy blocks. They used this new entity to continue the distribution of controlled substances.

The corporate indictment mirrors the charges leveled against the executives. Done Global faces maximum penalties equal to twice the gross profits of the operation. The company must defend against these charges while its founder and clinical president await sentencing. The Department of Health and Human Services Office of Inspector General labeled the operation one of the most egregious abuses of telehealth they have seen. The federal government established a clear legal framework to prosecute digital health platforms that operate as pill mills.

Following the executive convictions, federal prosecutors escalated their attack. On December 17, 2025, a federal grand jury indicted Done Global as a corporate entity. The charges mirror the executive convictions. Prosecutors allege the company operated a $100 million scheme to illegally distribute attention deficit hyperactivity disorder medications over the internet. The corporate indictment the financial infrastructure of the telehealth platform. The Department of Justice seeks to the corporate entity entirely.

The Department of Justice filed formal charges against Done Global and a Florida medical practice named Mindful Mental Wellness PA. Prosecutors accuse the entities of operating a massive prescription drug distribution ring. The federal grand jury in San Francisco returned the indictment on December 17, 2025. The charges include conspiracy to illegally distribute Adderall, four counts of illegal distribution of Adderall, conspiracy to commit health care fraud, and conspiracy to obstruct justice. Mindful Mental Wellness faces a charge of conspiracy to illegally distribute Adderall. The government alleges Done Global incorporated the Florida entity to bypass pharmacies that refused to fill prescriptions written by Done Global providers.

The financial scope of the operation is vast. Court documents show Done Global arranged the prescription of over 40 million pills of Adderall and other stimulants. The company generated over $100 million in revenue from this operation. Medicare, Medicaid, and commercial insurers paid out more than $14 million based on fraudulent claims. The company spent $40 million on deceptive social media advertisements. These advertisements targeted individuals experiencing isolation during the COVID 19 pandemic. The marketing campaigns convinced individuals they suffered from attention deficit hyperactivity disorder.

This corporate indictment directly follows the November 19, 2025 convictions of the top executives. A federal jury in the Northern District of California found founder Ruthia He and clinical president David Brody guilty of multiple felonies. The jury convicted both executives of conspiracy to distribute controlled substances, four counts of distribution of a controlled substance, and conspiracy to commit health care fraud. The jury also convicted Ruthia He of conspiracy to obstruct justice. The executives face a maximum penalty of 20 years in prison for the distribution charges. Their sentencing date is scheduled for February 25, 2026.

The obstruction of justice charges reveal a deliberate attempt to evade law enforcement. Prosecutors presented evidence that Ruthia He relocated company operations to China. This move aimed to restrict access to personnel and evidence. The executives destroyed incriminatory documents and communications. They transferred $1 million to a shell company in China. Ruthia He actively researched countries without extradition treaties with the United States. Done Global and Mindful Mental Wellness allegedly conspired to alter, destroy, or conceal records after receiving a grand jury subpoena. The Department of Justice noted these actions demonstrated a clear intent to hide the massive distribution network from federal investigators. The relocation strategy specifically targeted the jurisdiction of the United States courts.

The indictment details the clinical operations of the platform. Done Global operated a subscription model. Patients paid a monthly fee for access to stimulant prescriptions. The company pressured medical providers to write prescriptions without a legitimate medical purpose. Patients received prescriptions after brief video or audio calls. In instances, patients received prescriptions without any direct communication with a provider. The company established standardized prescribing rules and performance expectations. The platform structured patient encounters to limit their scope and duration. The system implemented automated refill processes and limited follow up care. Medical professionals faced termination if they refused to prescribe stimulants to patients. The platform restricted independent clinical practitioners from discharging patients. Patients continued to receive Adderall even after family members notified the company about severe adverse reactions. These reactions included bipolar episodes and Adderall induced psychosis.

The corporate entities face severe financial penalties if convicted. Done Global faces a maximum penalty for conspiracy and illegal distribution of Adderall equal to twice the gross profits or other proceeds. The company faces twice the gain or twice the gross loss for conspiracy to commit health care fraud and obstruction. Mindful Mental Wellness faces a maximum penalty of twice the gross profits or other proceeds for its role in the conspiracy. The Department of Justice seeks to hold the corporate entities accountable for defrauding federal health care programs and exploiting telehealth regulations. Acting Assistant Attorney General Matthew R. Galeotti stated the company used lies and deceit to carry out a sophisticated fraud scheme. The Drug Enforcement Administration noted the company betrayed the public trust by flooding the country with a highly regulated controlled substance.

Data forms the foundation of the government case. Court documents reveal that Done Global arranged for the prescription of more than 40 million pills of Adderall and other stimulants. This massive volume was achieved through a subscription based virtual platform. Patients paid a monthly fee for easy access to controlled substances. The sheer of the distribution network highlights the widespread absence of medical oversight. The 40 million pill metric be central to the corporate trial.

The Department of Justice records detail the exact volume of controlled substances distributed by the company. Prosecutors confirm that the operation dispensed 40 million doses of Adderall and related stimulants to patients across the country. This distribution network operated entirely through a digital interface. The founders designed the platform to maximize prescription volume. Medical professionals working for the company received compensation based strictly on the quantity of pills they prescribed. The corporate policy explicitly forbade paying these practitioners for the actual time they spent consulting with patients. Management mandated that all initial patient encounters last less than 30 minutes. This structure guaranteed a high volume turnover rate and a continuous flow of new prescriptions.

Financial records from the trial show the direct monetary result of this prescribing model. The company collected over $100 million in revenue from its subscriber base. Patients paid a recurring monthly fee to maintain their access to the stimulant prescriptions. To build this customer base, the executive team allocated $40 million toward social media advertising. These marketing campaigns specifically directed advertisements at individuals seeking drugs. The advertisements presented the platform as an easy way to obtain an attention deficit hyperactivity disorder diagnosis and the corresponding medication. The aggressive marketing strategy successfully converted internet users into paying subscribers.

The corporate entity faced a federal indictment on December 17, 2025. A grand jury in the Northern District of California charged Done Global and a Florida based company named Mindful Mental Wellness with conspiracy to illegally distribute Adderall. The government also charged the companies with conspiracy to commit health care fraud and conspiracy to obstruct justice. Court filings explain that Done Global created Mindful Mental Wellness to bypass retail pharmacies. By 2023, specific major pharmacy chains refused to fill prescriptions written by practitioners associated with the main company. The Florida entity served as a workaround to keep the pills flowing to the subscribers.

The financial damage extended beyond the individual subscribers paying monthly fees. The operation submitted fraudulent prior authorization requests to insurance providers. The company falsely claimed that its practitioners followed established diagnostic criteria and conducted urine drug screens. The paperwork also falsely stated that patients had tried non stimulant medications without success. Because of these fabricated claims, Medicare, Medicaid, and commercial insurers paid out an excess of $14 million. The fraudulent billing practices maximized the profitability of the 40 million pills.

The corporate indictment follows the individual convictions of the top executives. On November 19, 2025, a federal jury convicted founder Ruthia He and clinical president David Brody. The jury found them guilty of conspiracy to distribute controlled substances and conspiracy to commit health care fraud. Ruthia He also received a conviction for conspiracy to obstruct justice. The obstruction charges from the executives deleting documents and using encrypted messaging applications after receiving a grand jury subpoena. The upcoming corporate trial relies heavily on the same evidence used to convict the founders. The 40 million pill metric remains the primary focus of the prosecution.

The Drug Enforcement Administration actively participated in the investigation. Assistant Administrator Cheri Oz stated that the company treated highly regulated controlled substances as commodities. The agency confirmed that the distribution of 40 million doses prioritized profit over patient safety. The Justice Department classified this prosecution as the criminal drug distribution case against a digital health platform. Prosecutors maintain that the executives exploited the relaxed telehealth regulations implemented during the COVID 19 pandemic. The government views the corporate indictment as a required action to hold the entire business structure accountable for the illegal distribution network.

The clinical practices employed by the company directly violated standard medical procedures. Court documents show that practitioners prescribed stimulants to patients who did not meet the diagnostic criteria for attention deficit hyperactivity disorder. The platform provided dosages and combinations of medications that served no legitimate medical purpose. The government presented evidence that the executives continued these prescribing habits even after learning that specific patients had suffered overdoses. The business model relied on keeping patients subscribed. The company instructed its staff to authorize automatic refills without requiring follow up appointments. This hands off method ensured a continuous flow of revenue while completely abandoning patient care.

Financial and Distribution Metrics

Patient acquisition relied on aggressive and deceptive marketing. Evidence presented at trial showed that Ruthia He and David Brody spent over $40 million on social media advertising. The campaign specifically targeted drug seeking patients during the COVID 19 pandemic. The advertisements were designed to convince Americans they suffered from attention deficit hyperactivity disorder. This massive marketing expenditure prioritized subscriber growth over clinical validity. The return on investment was directly tied to illegal prescription volume.

The Department of Justice presented internal financial records detailing the advertising budget. Prosecutors proved that Done Global funneled tens of millions of dollars into Facebook, Instagram, TikTok, and Google. The marketing strategy capitalized on the relaxed prescribing regulations enacted during the COVID 19 public health emergency. The company bought targeted search advertisements aimed at internet users who wanted to obtain Adderall without a legal prescription. This method converted casual social media users into paying subscribers. Law enforcement officials subpoenaed the advertising records from the major technology companies to build their case against the executives.

The advertising content intentionally misled consumers. The digital campaigns suggested that normal pandemic related stress or boredom were medical symptoms of attention deficit hyperactivity disorder. The company used short video clips on TikTok to reach younger demographics. These videos minimized the serious nature of Schedule 2 controlled substances. The marketing materials guaranteed quick assessments and easy access to stimulant medications. The government used this advertising content and targeting data to prove criminal intent during the November 2025 trial. The advertisements created a false narrative that prescription stimulants were a simple lifestyle enhancement rather than a highly regulated medical treatment.

Financial incentives motivated the aggressive marketing push. The company operated on a subscription model where patients paid a monthly fee for access to prescribers. The $40 million advertising spend generated over $100 million in revenue. The platform arranged the distribution of more than 40 million Adderall pills. The corporate leadership viewed controlled substances as commodities to be marketed through memberships. The business model required a constant influx of new paying subscribers to sustain operations and enrich the executives. The return on investment for the advertising campaigns was calculated based on the number of new subscriptions and the volume of pills dispensed.

The marketing campaigns continued even as social media platforms attempted to restrict the content. By mid 2024, platforms like Google and TikTok banned advertisements from Done Global. The company continued its efforts to acquire new patients. The executives ignored warnings from family members who reported that patients experienced Adderall induced psychosis and bipolar episodes. The advertising operation kept running to replace patients who canceled their subscriptions or suffered adverse medical events. The leadership team refused to alter their marketing strategy even when confronted with direct evidence of patient harm.

The trial evidence revealed that Ruthia He instructed employees to prioritize growth. She told her staff that successful technology companies break rules. The digital marketing strategy functioned as the primary engine for the criminal conspiracy. The company paid nurse practitioners up to $60, 000 per month to process the massive volume of new patients generated by the advertisements. The clinical staff faced pressure to approve prescriptions for the newly acquired subscribers. The entire operation depended on the continuous flow of leads from the $40 million deceptive advertising campaign. The executives built an automated system designed to convert internet traffic into drug distribution channels.

State and federal authorities use the Done Global case as a template for prosecuting digital health platforms. The Department of Justice analyzes digital advertising campaigns, consumer acquisition costs, and conversion metrics to identify fraud. The government scrutinizes telehealth companies that use algorithm driven prescribing schemes and deceptive digital marketing. The conviction of Ruthia He and David Brody demonstrates that law enforcement can hold executives accountable for using social media to distribute controlled substances illegally. The December 2025 corporate indictment further solidifies the stance that companies cannot hide behind digital marketing to conduct criminal enterprises.

Operational roadblocks forced the company to adapt illegally. When major pharmacies began blocking prescriptions from Done Global providers, the company executed a workaround. The indictment alleges that Done Global incorporated Mindful Mental Wellness in Florida. This entity was created specifically to circumvent the pharmacy blocks. Mindful Mental Wellness is a co defendant in the corporate indictment. The use of a secondary medical practice demonstrates premeditated intent to bypass regulatory safeguards.

The Department of Justice unsealed the corporate indictment on December 17, 2025. Prosecutors charge that Mindful Mental Wellness operated as a direct extension of the primary enterprise. The secondary company maintained a registered agent in St. Petersburg, Florida, while operating out of the exact same San Francisco headquarters as Done Global. This structural overlap reveals the true nature of the operation. The Florida entity existed on paper to bypass the compliance filters of major retail pharmacies. By 2023, national pharmacy chains refused to fill prescriptions written by clinicians associated with the primary California corporation. To maintain the flow of controlled substances, executives routed new prescriptions through the Florida medical practice.

Mindful Mental Wellness supplied the prescribing clinicians for the platform. These practitioners authorized the distribution of highly addictive stimulants. The government states that clinicians prescribed medication without conducting proper medical examinations. In specific instances, patients received approvals without any video or audio communication. The operation targeted Medicare and Medicaid beneficiaries alongside patients with commercial insurance. The dual corporate structure allowed the enterprise to submit fraudulent claims to these insurers while hiding the origin of the prescriptions.

The size of the distribution network requires exact quantification. Between the start of the pandemic and the 2025 indictments, the combined entities facilitated the distribution of over 40 million pills. The operation generated more than 100 million dollars in subscription revenue. The financial motive drove the clinical decisions. The indictment specifies that the companies instructed prescribers to problem medication without a legitimate medical purpose. This directive aimed to increase monthly subscription retention and boost the corporate valuation.

The legal exposure for both entities is severe. Mindful Mental Wellness faces a maximum penalty of twice the gross profits or other proceeds derived from the conspiracy to distribute Adderall. Done Global faces identical financial penalties for the distribution charges, plus twice the gross gain or loss for the health care fraud and obstruction charges. The obstruction charges from allegations that the companies conspired to alter, conceal, and destroy records after receiving a federal grand jury subpoena.

The creation of Mindful Mental Wellness shows the premeditated nature of the fraud. When compliance departments at retail pharmacies identified irregular prescribing patterns, they severed ties with the primary company. Instead of correcting the clinical procedures, the enterprise built a new corporate vehicle to deceive the pharmacies. The Florida entity masked the origin of the prescriptions. This deception allowed the continued exploitation of patients and the systematic theft of public funds. Acting Assistant Attorney General Matthew R. Galeotti stated that the operation used lies and deceit to carry out the scheme.

The corporate indictment represents a direct attack on the structural operations of telehealth fraud. The Department of Justice treats the secondary medical practice not as an independent clinic, as a co conspirator in a massive drug distribution ring. The prosecution of Mindful Mental Wellness establishes a clear precedent. Federal authorities can pierce the corporate veil to prosecute shell companies designed to evade medical regulations. The deliberate routing of prescriptions through a secondary entity to bypass pharmacy blocks constitutes a serious criminal offense. This enforcement action signals that secondary corporate registrations cannot shield executives from federal drug distribution charges.

The cover up proved as damaging as the crime. Ruthia He was convicted of obstruction of justice based on extreme measures taken to thwart the investigation. She attempted to relocate Done Global to China to restrict access to personnel and evidence. She also transferred $1 million to a shell company in China and researched countries without extradition treaties. Executives deleted incriminatory documents and used encrypted messaging platforms to hide communications. These actions obliterate any defense of mere negligence.

Ruthia He recognized the severity of the federal probe and initiated a calculated extraction plan. Court records confirm she searched the internet for nations without extradition treaties with the United States. She prepared to abandon her California base and flee the jurisdiction permanently. Law enforcement intercepted her at the border as she attempted to exit the country. Her capture halted a deliberate scheme to evade prosecution and live off the proceeds of the telehealth fraud. Prosecutors presented this interception to the jury as definitive proof of her consciousness of guilt. The flight attempt destroyed any narrative that the company operated with transparency or cooperated with regulatory inquiries. The physical act of fleeing the country elevated the case from corporate negligence to intentional criminal evasion.

Financial records introduced at trial exposed a direct funnel of capital out of the United States. He authorized the transfer of more than $1 million to a Chinese shell company named Make Believe Asia. This transaction served to shelter assets from federal seizure and fund her planned overseas operations. The movement of $1 million into Make Believe Asia demonstrates a sophisticated effort to hide illicit profits from the Internal Revenue Service and the Drug Enforcement Administration. Investigators tracked the wire transfers and used the financial data to secure the obstruction conviction. The creation of a foreign entity specifically to receive diverted funds proves the executive team planned a long term evasion strategy. The financial maneuvering shows a clear intent to protect the wealth generated by the illegal distribution of 40 million Adderall pills.

Beyond personal flight, He orchestrated a corporate relocation to shield Done Global from federal subpoenas. She moved core operations to China to place personnel and digital evidence outside the reach of American law enforcement. By shifting the operational hub to a foreign jurisdiction, she intended to make key witnesses unavailable for grand jury testimony. The geographic relocation created immediate jurisdictional walls for the Department of Justice and the Department of Health and Human Services. Prosecutors argued this maneuver was a direct response to the escalating federal scrutiny and the issuance of grand jury subpoenas. The physical removal of the company infrastructure confirms a coordinated effort to obstruct justice. The executives prioritized their own survival over the health of their patients and the integrity of the medical system.

The obstruction extended deep into the digital infrastructure of Done Global. He and her associates systematically deleted incriminatory documents from company servers. Trial evidence showed they erased internal communications that explicitly encouraged medical providers to prescribe Adderall to patients who did not have an attention deficit hyperactivity disorder diagnosis. The executive team abandoned standard corporate email systems and transitioned to encrypted messaging applications. They activated auto delete message features to ensure their directives left no trace. This digital purge targeted the exact records federal investigators sought through grand jury subpoenas. The destruction of medical guidance documents proves the executives knew their prescribing mandates violated federal law. The deliberate erasure of evidence forced investigators to use advanced forensic techniques to reconstruct the criminal conspiracy.

The jury found the evidence of obstruction overwhelming. On November 19, 2025, the federal court convicted He of conspiracy to obstruct justice alongside the drug distribution and fraud charges. The obstruction conviction carries severe sentencing consequences. Federal sentencing guidelines heavily penalize defendants who destroy evidence or attempt to flee the jurisdiction. The deliberate nature of the cover up guarantees a harsher penalty at the upcoming sentencing hearing. The Department of Justice highlighted the obstruction charges to warn other digital health executives that concealing fraud guarantees aggressive prosecution. The calculated destruction of records and the aborted flight to China cement the criminal legacy of the Done Global leadership. The obstruction charges validate the federal strategy of pursuing corporate executives who attempt to hide their illegal operations behind digital encryption and international borders.

The financial architecture of Done Global incentivized overprescribing. The company operated on a subscription based model where individuals paid a monthly fee for continuous access to medication. The prescriber compensation structure was allegedly designed to discourage follow up care. Providers were paid based on patient volume rather than clinical outcomes. This model transformed medical care into a transactional commodity. The monthly recurring revenue depended entirely on maintaining active stimulant prescriptions.

The following 20 questions examine the financial metrics and operational data of the company.

1. What was the initial evaluation cost for a new patient? The company charged 299 dollars for the appointment.

2. What was the monthly membership fee? Patients paid 79 dollars every month for continued access.

3. Did the company accept insurance for the monthly subscription fee? The company did not accept insurance for the membership cost.

4. How much total revenue did the company generate? The operation produced over 100 million dollars in revenue.

5. How pills were prescribed through the platform? Providers authorized over 40 million pills.

6. How were prescribers compensated? The company paid providers based on the number of patients receiving prescriptions.

7. Were prescribers paid for medical visits? The company refused to pay providers for medical visits.

8. Were prescribers paid for telemedicine consultations? The company provided no compensation for telemedicine consultations.

9. Were prescribers paid for time spent caring for patients after the initial consultation? The company offered zero pay for follow up care.

10. What was the maximum duration mandated for initial encounters? The platform required initial appointments to remain under 30 minutes.

11. Did the platform use an automatic refill function? The system featured an automatic refill button for subscribers.

12. How much did the company spend on social media advertisements? The company allocated over 40 million dollars to social media marketing.

13. What was the primary goal of the conspiracy according to the Department of Justice? The objective was to unlawfully enrich the defendants by increasing monthly subscription revenue.

14. Did the company provide full patient information to prescribers? The platform intentionally limited the medical history available to providers.

15. Did the compensation structure encourage follow up care? The payment method actively discouraged providers from conducting follow up evaluations.

16. What controlled substance was primarily distributed? The platform focused heavily on distributing Adderall.

17. Did the company require patients to try non stimulants? The company falsely told insurance providers that patients had tried non stimulants.

18. Were patients required to take urine drug screens? The company submitted fraudulent claims stating patients had completed urine drug screens.

19. Did the company follow the DSM 5 guidelines for diagnosing attention deficit hyperactivity disorder? The company falsely claimed compliance with the DSM 5 guidelines.

20. When did the events principally occur? The Department of Justice focused on activities between February 2020 and January 2023.

The Department of Justice detailed how the company built a financial engine that prioritized patient volume over medical care. The company charged patients a 299 dollar initial evaluation fee. After the appointment, patients paid a 79 dollar monthly membership fee. This recurring revenue model required active prescriptions to maintain subscriber retention.

The compensation structure for medical providers directly supported this revenue model. The Department of Justice found that the company refused to pay prescribers for medical visits. The company refused to pay for telemedicine consultations. The company refused to pay for time spent caring for patients after the initial consultation. Instead, the company paid prescribers solely based on the number of patients who received prescriptions.

This payment method discouraged follow up care. Providers faced financial penalties for spending time on patient evaluations that did not result in a prescription. The platform mandated that initial encounters remain under 30 minutes. The system limited the medical history and information available to the prescribers. The company instructed providers to prescribe Adderall even if the patient did not qualify.

Once a patient received a prescription, the platform activated an automatic refill function. Subscribers could request a refill every month with a single click. This feature minimized provider interaction and maximized subscription retention. The company generated over 100 million dollars in revenue through this system. The platform arranged for the prescription of over 40 million pills.

The company spent over 40 million dollars on social media advertisements to acquire these subscribers. The advertisements targeted individuals seeking stimulants. The Department of Justice stated that the primary purpose of the conspiracy was to increase monthly subscription revenue. This revenue growth increased the in total valuation of the company.

The company submitted false prior authorization requests to insurance companies to cover the cost of the medications. The company falsely claimed that providers followed the DSM 5 guidelines for diagnosing attention deficit hyperactivity disorder. The company falsely claimed that patients had tried non stimulants without success. The company falsely claimed that patients had completed urine drug screens. These fraudulent claims led insurers to pay out over 14 million dollars.

The financial damage extended to taxpayer funded programs. Done Global and Mindful Mental Wellness allegedly ordered stimulants for Medicare and Medicaid beneficiaries without a legitimate medical purpose. Providers absence a preexisting practitioner patient relationship. Prescriptions were frequently issued based on a short video or audio communication, and sometimes without any direct communication at all. The conspiracy to commit health care fraud charge directly from these false claims submitted to federal insurers.

The Department of Justice proved that Done Global executives submitted false prior authorization requests to federal and commercial insurers. These documents falsely claimed that the company followed the Diagnostic and Statistical Manual of Mental Disorders criteria for diagnosing attention deficit hyperactivity disorder. The executives also lied about using urine drug screens to monitor patients. They falsely stated that non stimulant medications had previously been tried without success. This deception caused Medicare, Medicaid, and commercial insurers to pay more than $14 million. Taxpayers bore a large financial cost for these medically unnecessary prescriptions.

By 2023, major pharmacies began blocking prescriptions from Done Health. To bypass these blocks, Ruthia He and David Brody incorporated Mindful Mental Wellness in Florida. They used this new entity to continue funneling prescriptions to Medicare and Medicaid patients. The government indicted both companies on December 17, 2025. The corporate indictment charges the entities with conspiracy to commit health care fraud. The government showed that the companies incorporated the Florida clinic specifically to evade detection and continue billing federal programs.

The jury convicted He and Brody of conspiracy to commit health care fraud on November 19, 2025. The corporate indictment followed one month later. If convicted, the companies face maximum penalties of twice the gross profits or twice the gross loss for the health care fraud conspiracy. Prosecutors demonstrated that the platform prioritized subscription revenue over patient safety. The company generated over $100 million in total revenue while distributing 40 million pills. The financial motive drove the entire operation.

The telehealth platform operated on an auto refill system. Patients paid a monthly subscription fee to access the service. To keep patients paying, the company needed insurance to cover the cost of the actual drugs at the pharmacy. Staff members systematically falsified patient records to ensure approval from federal programs. They bypassed standard medical guidelines and ignored signs of drug diversion. The business model relied on continuous billing to Medicare and Medicaid to sustain its operations.

The Centers for Medicare and Medicaid Services partnered with the Office of Inspector General to investigate the billing irregularities. Deputy Inspector General Christian J. Schrank called the operation a severe abuse of telehealth. The Drug Enforcement Administration noted that the company exploited public health emergency rules to push prescription medication. The government is using this case as a model to prosecute other digital health platforms that defraud federal insurers. The conviction of the top executives provides a clear legal precedent for the ongoing corporate prosecution.

Federal investigators found that the company instructed clinicians to prescribe stimulants without conducting proper medical evaluations. The compensation structure rewarded providers based on the volume of prescriptions rather than the quality of care. This volume based model directly contributed to the large number of false claims submitted to Medicare and Medicaid. The company actively misled pharmacies and insurers by concealing the true nature of their online prescribing practices. The Department of Justice continues to pursue maximum penalties to recover the stolen public funds.

The prosecution marks the time the federal government has targeted a digital health company for criminal drug distribution and health care fraud. The case establishes a new standard for holding telehealth corporations accountable for their billing practices. The evidence presented at trial confirmed that the executives knew their actions violated federal law. They continued to submit fraudulent claims even after receiving warnings about patient overdoses. The ongoing corporate trial can result in the complete closure of Done Global and Mindful Mental Wellness.

Prosecutors used data analysis to track the flow of fraudulent claims from the telehealth platform to federal insurers. The Criminal Division Fraud Section led the investigation into the billing patterns. They identified specific instances where the company billed Medicare for patients who never spoke to a doctor. The data showed a clear pattern of intentional fraud designed to increase corporate profits. The successful conviction of the executives confirms the analytical methods used by federal investigators.

The legal for telemedicine shifted dramatically. The Ryan Haight Online Pharmacy Consumer Protection Act strictly regulates the online distribution of controlled substances. During the COVID 19 pandemic, temporary federal emergency rules allowed clinicians to prescribe these medications without an in person examination. Done Global exploited these temporary flexibilities to rapidly. As these emergency rules expire, the operational viability of such platforms collapses. The Department of Justice is enforcing the original statutory boundaries.

Congress enacted the Ryan Haight Act in 2008. The statute requires a medical practitioner to conduct at least one in person medical evaluation before prescribing Schedule II through V controlled substances. The law the illegal distribution of prescription drugs over the internet. The Support for Patients and Communities Act of 2018 mandated the Drug Enforcement Administration to create a special registration process for telemedicine providers. The agency did not finalize this registration process before the COVID 19 public health emergency began in March 2020. The absence of a permanent regulatory framework left the industry dependent on emergency declarations.

The federal government enacted temporary waivers in March 2020. The Drug Enforcement Administration and the Department of Health and Human Services allowed practitioners to prescribe controlled substances via telemedicine without an initial in person visit. Done Global built a business model around this temporary waiver. The company charged patients a monthly subscription fee for access to clinicians. These clinicians prescribed Adderall and other stimulants after brief online consultations. Done Global arranged the prescription of over 40 million pills between 2020 and 2023. The company generated over $100 million in revenue during this period. The Department of Justice reported that health plans and federal programs paid $14 million for these claims. The platform expanded its operations by exploiting the suspended statutory restrictions.

Federal authorities initiated enforcement actions as the public health emergency concluded. The Drug Enforcement Administration began investigating Done Global in 2022. The Department of Justice indicted Done Global executives Ruthia He and David Brody in June 2024. The indictment charges the executives with conspiracy to distribute controlled substances and health care fraud. Prosecutors allege the company instructed prescribers to distribute highly addictive medications even when patients did not meet clinical criteria. The government asserts the company based compensation primarily on the volume of prescriptions. The indictment marks the federal prosecution of criminal drug distribution related to telemedicine prescribing by a digital health company. The authorities arrested the executives in California and filed the charges in the United States District Court for the Northern District of California.

The Drug Enforcement Administration issued multiple temporary extensions to prevent a sudden loss of medical care. The agency published a third temporary rule in November 2024. This rule extended the prescribing flexibilities through December 31, 2025. The Biden administration released a proposed rule in January 2025. This proposed rule outlines a special registration pathway for telehealth practitioners to prescribe certain controlled substances. The federal government requires providers to comply with strict documentation and reporting standards under this proposed framework. The proposed rule establishes three distinct special registrations for telehealth practitioners and online platforms.

The criminal charges against Done Global demonstrate the strict enforcement of the Controlled Substances Act. The Department of Justice treats the exploitation of pandemic emergency rules as criminal drug distribution. The expiration of the temporary waivers forces telehealth companies to restructure their operations. Companies must secure special registrations or mandate in person visits for their patients. The federal government holds corporate executives criminally liable for operating digital platforms that bypass statutory medical evaluation requirements. The Done Global indictment establishes a clear legal precedent for prosecuting telehealth platforms that distribute controlled substances without valid medical need. The federal government continues to scrutinize digital health companies that prioritize subscription revenue over verified medical evaluations.

The line of defense against the scheme came from the private sector. Retail pharmacies noticed the anomalous prescribing patterns and began refusing to fill orders from Done Global clinicians. This pushback threatened the core business model. The company response was to create Mindful Mental Wellness to hide the origin of the prescriptions. The pharmacy blockade highlights the serious role of pharmacists in the controlled substance supply chain. Their refusal to dispense triggered federal scrutiny.

In April 2022, major retail pharmacy chains began blocking prescriptions originating from Done Global and similar telehealth platforms. Pharmacists hold a corresponding responsibility under the Controlled Substances Act. This legal standard requires pharmacists to ensure that prescriptions for controlled substances serve a legitimate medical purpose. When pharmacists observe red flags, they face personal liability and chance Drug Enforcement Administration enforcement actions if they dispense the medication.

Pharmacists operate under strict federal guidelines. The corresponding responsibility doctrine dictates that a pharmacist cannot blindly follow a physician order. If a prescription appears suspicious, the pharmacist must verify its legitimacy. In the case of Done Global, pharmacists noticed a high volume of stimulant prescriptions originating from a single telehealth source. They also observed that patients received maximum doses without proper titration or follow up care. These patterns constituted severe red flags. The Drug Enforcement Administration holds pharmacists criminally liable if they ignore these warning signs. Recent enforcement actions against major pharmacy chains for dispensing invalid prescriptions pushed these corporations to adopt stricter vetting processes.

Walmart confirmed in April 2022 that it blocked certain Done clinicians from sending prescriptions to its stores. The corporation implemented this block following an internal audit and compliance review. CVS Health followed suit shortly after. On May 26, 2022, CVS Pharmacy officially stopped accepting prescriptions for controlled substances written by Done Health. CVS executives stated they could not resolve their concerns regarding the prescribing practices of the telehealth company. Walgreens Boots Alliance and smaller pharmacy startups like Capsule also delayed or blocked prescriptions from Done providers during this period.

The refusal by these pharmacies created a major obstacle for the Done Global business model. Customers paid a monthly subscription fee specifically to obtain Adderall and other stimulants. When retail pharmacies refused to fill the orders, subscribers could not access the drugs. This situation directly threatened the revenue stream of the company. By 2023, the pharmacy blockade became a widespread obstacle for the telehealth provider.

To bypass the pharmacy restrictions, Done Global executives executed a corporate maneuver. According to the December 2025 federal indictment, the company incorporated Mindful Mental Wellness P. A. in Florida. Done Global used this new entity to disguise the origin of the prescriptions. Clinicians routed their Adderall orders through Mindful Mental Wellness to evade the blocks established by CVS, Walmart, and Walgreens.

This evasion tactic allowed the company to continue its operations temporarily. The Department of Justice reported that Done Global and Mindful Mental Wellness conspired to distribute over 40 million pills. The network generated over $100 million in revenue through this process. The creation of the Florida shell company demonstrated a deliberate effort to deceive the pharmacists who had previously rejected the prescriptions.

The actions of the retail pharmacies served as an early warning system for federal investigators. The Drug Enforcement Administration began investigating Done Global in September 2022, shortly after the major pharmacy chains implemented their blocks. The private sector compliance measures forced the company to adopt deceptive routing practices. These deceptive practices later formed the basis for the federal health care fraud and obstruction charges filed in December 2025.

The indictment attacks the structural legality of the enterprise. The Department of Justice alleges that the defendants violated the long standing prohibition against the corporate practice of medicine in California. Ruthia He and David Brody allegedly created the false appearance that Done Health was an independent medical practice. In reality, the corporate entity dictated clinical decisions to maximize profit. This structural flaw exposes the entire management services organization model to criminal liability.

The professional corporation and management services organization structure serves as the foundation for most digital health platforms. State laws prohibit lay entities from practicing medicine. Technology companies establish a management services organization to handle administrative tasks to bypass this restriction. A licensed physician owns the professional corporation and oversees clinical care. The Department of Justice invalidated this separation in the Done Global prosecution. Prosecutors proved that the management services organization exercised absolute control over the professional corporation. The corporate entity dictated patient encounter durations and established standardized prescribing rules.

Federal investigators documented specific instances of clinical interference. The corporate entity mandated that initial patient consultations last no longer than 30 minutes. The management services organization also tied prescriber compensation directly to prescription volume rather than care quality. The platform deployed automated refill technology that dispensed Schedule II stimulants without adequate clinical reassessment. Prosecutors argued that these operational mandates stripped licensed clinicians of their independent medical judgment. The corporate practice of medicine doctrine transitioned from a state level administrative compliance matter into a federal criminal evidentiary weapon.

The enterprise distributed over 40 million pills of Adderall and other stimulants between 2020 and 2023. The corporate entity spent 40 million dollars on deceptive social media advertising to attract drug seeking patients. This marketing budget dwarfed the resources allocated to clinical compliance. The management services organization designed the platform to limit the information available to prescribers. This design choice ensured that clinicians approved prescriptions quickly to maintain the high volume required by the corporate financial model. The Department of Justice presented these facts to prove that the corporate entity operated a drug distribution ring disguised as a medical practice.

The government did not charge the corporate practice of medicine violation as a standalone federal offense. Prosecutors used California state law as an evidentiary predicate to secure convictions under the Controlled Substances Act. By proving that the management services organization controlled the medical practice, the Department of Justice demonstrated that prescriptions carried no legitimate medical purpose. The November 2025 jury verdict against Ruthia He and David Brody validated this legal theory. The December 2025 superseding indictment against the corporate entity cemented the precedent. Investors and executives who direct clinical operations through a management services organization face direct criminal exposure.

This prosecution redefines operational boundaries for telehealth platforms. Technology companies can no longer hide behind a physician owned professional corporation while dictating clinical workflows. The Department of Justice actively prosecutes algorithms that steer clinical decisions. Federal prosecutors view software that overrides medical judgment as a method for unlawful drug distribution. The 100 million dollars in revenue generated by Done Global served as proof of motive. The corporate entity prioritized subscription fees over patient safety.

The trial exposed the financial architecture of the scheme. The management services organization collected the subscription revenue and controlled the technology infrastructure. The professional corporation existed only on paper to satisfy state licensing boards. David Brody held the title of clinical president and sole shareholder of Done Health. Prosecutors presented evidence showing he possessed no actual authority over the medical practice. Ruthia He and the corporate executive team made all operational decisions. This total corporate dominance over medical professionals provided the foundation for the conspiracy and drug distribution convictions.

The clinical workforce was allegedly deployed illegally. The indictment claims that executives caused practitioners to prescribe for patients in states where they absence appropriate licensure. also, the company allegedly violated state physician supervision and collaboration laws applicable to nurse practitioners. By utilizing mid level providers across state lines without proper oversight, the company minimized costs and maximized prescription output. This exploitation of the nursing workforce forms a key pillar of the fraud charges.

The Department of Justice details a deliberate corporate strategy to bypass medical licensing laws. Executives Ruthia He and David Brody directed the company to hire nurse practitioners and deploy them across state boundaries. These mid level providers evaluated patients and prescribed controlled substances in jurisdictions where they held no legal authority to practice medicine. State laws mandate specific physician supervision for nurse practitioners. The company ignored these legal boundaries to reduce overhead costs and accelerate the volume of stimulant prescriptions.

Federal prosecutors identified specific financial incentives designed to manipulate provider behavior. The company paid nurse practitioners based solely on the volume of patient encounters. Management capped initial consultations at 30 minutes. Executives instructed providers to authorize Adderall prescriptions even when patients did not meet the clinical criteria for an attention deficit hyperactivity disorder diagnosis. Providers received up to $60, 000 per month for their participation. This compensation structure rewarded rapid prescribing and penalized thorough medical evaluations.

The autorefill policy represents another severe violation of medical standards. The platform generated automatic prescription renewals for controlled substances without requiring any audio or visual communication between the patient and the provider. Nurse practitioners approved these automated requests blindly. The indictment highlights that providers continued to problem Adderall prescriptions for patients who had already died from drug overdoses. This automated dispensing system removed all clinical oversight from the prescribing process.

The government singled out several nurse practitioners for their extraordinary prescription volumes. Florida based nurse practitioner Erin Eunah Kim prescribed over 1. 5 million pills of Adderall and other stimulants. She received over $821, 350 in compensation from the company between January 2021 and January 2023. The Department of Justice charged Kim and other providers including Yina Cruz and Katrina Pratcher with conspiracy to distribute controlled substances. These individual prosecutions demonstrate the direct legal consequences for clinical staff who participate in corporate fraud schemes.

The financial data reveals the massive scope of this operation. The company generated over $100 million in revenue by dispensing more than 40 million stimulant pills. Nurse practitioners served as the primary engine for this revenue generation. By removing physician oversight and ignoring state licensing boards, the executives built a highly profitable dispensing network. The November 2025 convictions of He and Brody confirm that federal courts view this business model as a criminal enterprise rather than a legitimate medical practice.

State medical boards establish strict collaboration agreements to ensure patient safety. A nurse practitioner must maintain a documented relationship with a supervising physician to prescribe Schedule II narcotics in jurisdictions. Done Global fabricated the appearance of these supervisory relationships. The corporate entity interfered directly with clinical decision making. Management discouraged follow up appointments and restricted the medical information available to the prescribing nurses. This interference nullified any genuine medical supervision and reduced the providers to prescription generators.

The federal government seized assets and halted the corporate operations to stop the illegal dispensing. The Drug Enforcement Administration noted that the company targeted individuals suffering from addiction who sought stimulants. The platform used deceptive social media advertisements to funnel patients directly to the nurse practitioners. The providers then acted as rubber stamps for the requested medications. This coordinated effort between corporate marketing and unlicensed clinical dispensing forms the foundation of the December 2025 corporate indictment against Done Global.

The corporate leadership actively concealed these licensing violations from federal regulators. When the Drug Enforcement Administration initiated its investigation, executives instructed the clinical staff to alter patient files and fabricate medical histories. The November 2025 trial evidence proved that the company transferred operations to foreign jurisdictions to hide the illegal prescribing data. This obstruction of justice charge solidifies the criminal nature of the enterprise. The systematic exploitation of nurse practitioners was not an administrative error a calculated method to defraud the healthcare system.

The financial survival of Done Global is mathematically improbable. If convicted, the corporation faces a maximum penalty for conspiracy and illegal distribution of twice the gross profits or other proceeds. The penalty for health care fraud could be twice the gain or twice the gross loss. Given the $100 million revenue figure, the fines could easily exceed $200 million. The government is also pursuing asset forfeiture. These financial liabilities guarantee corporate insolvency.

The Department of Justice secured convictions against founder Ruthia He and clinical president David Brody on November 19, 2025. Prosecutors proved the executives operated a scheme generating over $100 million in revenue through the distribution of 40 million Adderall and stimulant pills. In December 2025, a federal grand jury indicted the corporate entity, Done Global. The corporate indictment activates severe statutory multipliers. Under federal sentencing guidelines, corporate defendants face fines calculated by multiplying the pecuniary gain. Because the enterprise generated $100 million, the baseline fine for the controlled substances conspiracy reaches $200 million.

Healthcare fraud convictions trigger additional financial devastation. The False Claims Act imposes civil monetary penalties ranging from $10, 781 to $21, 563 per claim. The government proved Done Global submitted false prior authorizations and fraudulent reimbursement claims to Medicare, Medicaid, and commercial insurers. Prosecutors established that the platform dispensed 40 million pills. If even a fraction of these prescriptions resulted in false claims, the penalties alone run into the hundreds of millions. The statute mandates treble damages. This means the government extracts three times the amount paid out for fraudulent claims. The Department of Justice does not negotiate these multipliers down when the defendants proceed to trial and lose. The civil judgments attach to the corporate entity and cannot be discharged in standard bankruptcy proceedings.

Asset forfeiture operations run parallel to the statutory fines. The Department of Justice actively seizes bank accounts, real estate, and investments tied to the proceeds of the conspiracy. Prosecutors documented that He and Brody transferred $1 million to a shell company in China and spent $40 million on deceptive social media advertising. The government pursues the remaining capital. Federal forfeiture laws permit the seizure of any property derived from proceeds traceable to health care fraud or controlled substance distribution. The seizure of operating accounts immediately halts payroll, vendor payments, and server maintenance. The Internal Revenue Service Criminal Investigation division tracks the flow of the $100 million to locate hidden assets. Any funds paid to executives, shareholders, or shell entities remain subject to clawback provisions.

The collateral financial consequences permanently terminate business operations. A corporate conviction for health care fraud results in mandatory exclusion from all federal health care programs. This includes Medicare, Medicaid, and Tricare. Private insurers mirror these exclusions. They drop the provider from their networks and demand refunds for past reimbursements. The Drug Enforcement Administration revokes the corporate registration required to handle controlled substances. Without DEA registration, the platform cannot legally transmit prescriptions for Schedule II stimulants. This ends the primary revenue stream of the company.

The financial math leaves no room for corporate survival. The $100 million revenue figure represents gross receipts. It does not represent retained earnings. The $40 million spent on advertising and the compensation paid to prescribers based on prescription volume consumed a heavy portion of the cash flow. The corporation does not possess the liquidity to pay a $200 million fine, treble damages, and civil penalties. The asset forfeiture actions freeze whatever cash remains in the corporate treasury. The cost of legal defense further drains the accounts. The combination of DEA registration revocation, federal program exclusion, and nine figure financial penalties guarantees the liquidation of Done Global.

The shockwaves from this prosecution are reshaping the industry. The Department of Justice has signaled that it aggressively pursue other virtual health platforms engaged in similar conduct. Investors are acutely aware of the enforcement risks associated with management services organizations in the telehealth sector. The era of venture capital funded, hyper growth controlled substance prescribing is over. Legitimate behavioral health providers must navigate a highly suspicious regulatory environment.

The Centers for Disease Control and Prevention released a health advisory warning that the disruption of Done Global operations affects 30, 000 to 50, 000 patients across 50 states. Medical records confirm 8. 7 million American adults have an attention deficit hyperactivity disorder diagnosis. The sudden removal of a major prescriber worsens an ongoing two year absence of stimulant medications like Adderall and Vyvanse. The federal agency advised patients against seeking treatments from illegal drug markets due to the risk of counterfeit pills mixed with fentanyl. Untreated attention deficit hyperactivity disorder correlates with adverse outcomes including substance abuse, unintentional injuries, suicide, and gambling problems. The Food and Drug Administration predicted medical use of Adderall, Ritalin, and Vyvanse to climb 3. 1 percent in 2024. The federal agency attributed the ongoing medication absence to increased prescribing linked to telemedicine growth, supply chain problems, and manufacturing delays.

Federal prosecutors secured convictions against the founder and the clinical president in November 2025. A corporate indictment followed in December 2025. The company generated $100 million in revenue by arranging the distribution of 40 million pills. This prosecution marks the criminal drug distribution case against a telemedicine company. The Department of Justice proved the company instructed prescribers to dispense stimulants without a legitimate medical purpose to boost subscription revenue. Done Global ordered Adderall for members of Medicare, Medicaid, and commercial insurers without establishing a valid practitioner and patient relationship. Clinicians dispensed controlled substances without an examination or based solely on a short audio communication. Drug Enforcement Administration Administrator Anne Milgram stated the defendants made millions of dollars by pushing addictive medications during a public health emergency.

Venture capital funding for digital health reached $10. 1 billion across 497 deals in 2024. Adjusted for inflation, this funding level matched the amount raised in 2019 before the pandemic era boom. Investors shifted focus away from direct to consumer controlled substance platforms. Funding grew to $14. 2 billion in 2025. Artificial intelligence companies captured 54 percent of that capital. Traditional virtual care providers received a shrinking share of investments. Mental health funding suffered steep declines in North America as financiers demanded clinical proof and strict compliance over rapid patient acquisition. Megadeals over $100 million accounted for 42 percent of the total investment in 2025. Corporations and investors demand concrete outcomes over experimental ventures.

The Done Global case exposes how corporate entities can improperly influence clinical decision making. The government targeted the management services organization structure. Prosecutors demonstrated that the company used a shell corporation named Mindful Mental Wellness in Florida to bypass pharmacies that blocked their prescriptions. By 2023, certain pharmacies refused to fill prescriptions written by prescribers retained by Done Health, a California company affiliated with Done Global. The corporate entity also deleted documents and used encrypted messaging to obstruct a grand jury subpoena. Legal analysts note that the prosecution shows federal attention to how telehealth platforms operate in practice, focusing on governance, compensation, and platform design. The government contended that management influence over clinical decisions proved the prescriptions were written outside the usual course of professional practice.

The Drug Enforcement Administration faces pressure to tighten telemedicine prescribing rules. The exploitation of pandemic era waivers by virtual platforms forces a regulatory correction. The allowance for asynchronous or brief video consultations for Schedule II narcotics faces strict curtailment. Legitimate behavioral health providers must absorb higher compliance costs to prove their medical justification standards. The market correction eliminates the hyper growth models that defined the early decade. Telehealth companies can no longer rely on aggressive social media advertising to acquire patients for controlled substances. The millions spent on deceptive advertising by Done Global serves as a warning to investors. Future investments require rigorous medical oversight and verifiable patient outcomes.

The broader digital health sector experienced a decline in exit activity during the half of 2025. The market recorded only six initial public offerings and 107 mergers and acquisitions. Public listings remain a challenging exit option for private equity backed companies. Liquidity remains a serious concern for limited partners in the broader private capital markets. The average time for venture capital funds to close nearly doubled. Investors scrutinize management services organizations for any signs of improper clinical influence. The conviction of Done Global executives proves that corporate officers face prison time for prioritizing subscription revenue over patient safety.

Federal agencies are building the infrastructure for future prosecutions. The Drug Enforcement Administration has proposed enhanced recordkeeping requirements specifically for telemedicine. These rules are designed to create a clear paper trail for enforcement actions. The agency submitted a proposed rule regarding telemedicine prescribing without prior in person evaluations to the White House on the exact day the Done Global arrests were announced. The regulatory net is tightening around the entire digital health ecosystem.

On June 13, 2024, the Department of Justice unsealed the indictment against Done Global executives Ruthia He and David Brody. On that exact day the Drug Enforcement Administration submitted a proposed rule to the White House Office of Management and Budget. This rule targeted telemedicine prescribing of controlled substances without prior in person medical evaluations. The timing signals a coordinated federal strategy to regulate digital health platforms. The agency received over 38, 000 public comments regarding earlier iterations of these rules. The volume of feedback forced the agency to revise its initial proposals and draft new requirements for online prescribers.

On January 17, 2025, the Drug Enforcement Administration published the Special Registrations for Telemedicine and Limited State Telemedicine Registrations Notice of Proposed Rulemaking. This framework introduces a new category of regulated entity called a covered online telemedicine platform. Digital health companies must register directly with the federal government. The proposed Special Registration requires an $888 fee. Registrants must renew this credential every three years. Practitioners must obtain state registrations for every state where they treat a patient. The rule mandates audio video telecommunications for all special registration prescriptions.

Data reporting forms the core of the new enforcement strategy. Special registrants must report prescription data to the Drug Enforcement Administration annually. The reports must include the total number of new patients in each state and the total number of special registration prescriptions authorized. Practitioners must check Prescription Drug Monitoring Programs across all 50 states before writing prescriptions. The agency designed these requirements to detect high volume prescribing patterns early. The rules apply specifically to Schedule III through V controlled substances.

The agency extended COVID 19 telemedicine flexibilities multiple times to prevent immediate disruptions in care. On December 31, 2025, the Drug Enforcement Administration published a fourth temporary rule. This action extended the flexibilities through December 31, 2026. The extension prevents an immediate lapse in prescribing authority while the agency finalizes permanent regulations. The temporary rules allow practitioners to prescribe Schedule II through V controlled substances without an initial in person medical evaluation.

The proposed regulations establish strict boundaries for online pharmacies and digital health platforms. The Drug Enforcement Administration seeks to eliminate the business models that rely entirely on virtual interactions. The January 2025 proposal requires companies to maintain physical clinic locations in the states where they operate. Psychiatrists must be physically located in the same state as the patient during the consultation. This geographical restriction directly attacks the operational structure of companies like Done Global. The agency intends to stop clinicians from operating exclusively through digital channels without brick and mortar practices.

The financial cost of compliance reshapes the digital health market. The $888 special registration fee applies to each individual practitioner. A telehealth company employing one thousand doctors faces nearly one million dollars in federal registration costs alone. The requirement to obtain state level registrations adds another level of expense. Practitioners must secure licenses in every jurisdiction where their patients reside. The administrative overhead required to track 50 different Prescription Drug Monitoring Programs forces companies to build expensive new software systems.

The agency also introduced a separate Advanced Telemedicine Prescribing Registration. This credential applies to specialized medical providers including psychiatrists and hospice care physicians. The advanced registration permits the prescription of Schedule II medications. The agency identified these drugs as highly addictive and prone to diversion into the illegal drug market. The standard Telemedicine Prescribing Registration only authorizes the prescription of Schedule III through V controlled substances. This tiered system creates a clear hierarchy of regulatory scrutiny based on the addiction risk of the prescribed medications.

The Department of Justice and the Drug Enforcement Administration are sharing data to build criminal cases. The annual reporting requirements force companies to hand over their prescribing metrics directly to federal investigators. If a platform shows an unusually high ratio of prescriptions to patient visits the agency can immediately flag the company for investigation. The rules require the establishment of a national Prescription Drug Monitoring Program to track these metrics across state lines. This centralized database gives prosecutors a complete view of a company prescribing habits. The federal government is building a surveillance network to monitor every digital prescription written in the United States.

The November 2025 convictions of Ruthia He and David Brody triggered an immediate halt to prescribing operations at Done Global. This abrupt cessation stranded between 30, 000 and 50, 000 patients across all 50 states. The Centers for Disease Control and Prevention issued a Health Alert Network advisory warning of severe care interruptions. The December 17, 2025 corporate indictment of Done Global and Mindful Mental Wellness PA permanently dismantled the corporate entity. The sudden collapse of this prescribing network left thousands of patients without access to their daily medications. Individuals who relied on the platform face abrupt discontinuation of their treatment plans.

Done Global distributed over 40 million pills and generated 100 million dollars in revenue. The platform used an auto refill function that bypassed standard medical evaluations and discouraged follow up appointments. Patients obtained monthly stimulant prescriptions through automated emails with zero clinical interaction. When the Department of Justice dismantled this pipeline, patients who developed dependencies faced sudden withdrawal. The Centers for Disease Control and Prevention warned that displaced individuals might turn to the illicit drug market. This shift increases the risk of fatal overdoses from counterfeit pills laced with fentanyl. Untreated attention deficit hyperactivity disorder correlates with adverse outcomes including drug abuse, unintentional injuries, and suicide.

Legitimate psychiatric providers and local health systems absorbed the shockwave. Triaging these displaced subscribers proved difficult because Done Global mandated initial consultations under 30 minutes and maintained substandard clinical documentation. Legitimate doctors could not easily verify previous diagnoses. This influx of patients coincided with a severe national absence of immediate release amphetamine mixed salts. In 2023, 97 percent of independent pharmacy owners reported Adderall scarcities. This supply constraint through 2025 and affected other medications including Zenzedi, Ritalin, Focalin, and Vyvanse. Patients frequently drive hours away from their homes to locate pharmacies with available inventory.

The Department of Justice prioritized the eradication of a 100 million dollar criminal enterprise over the clinical management of its user base. The government treated Done Global as a drug trafficking operation rather than a medical institution. Federal investigators described a system engineered to provide easy access to stimulants under the guise of convenience. This enforcement strategy dismantled the illegal distribution network offered no transitional care plan for the tens of thousands of subscribers. The resulting scenario represents a massive public health emergency. Corporate executives exploited telehealth regulations for financial gain and left the public health sector to manage the.

Federal officials acknowledge the severity of the situation. The Centers for Disease Control and Prevention explicitly advised health care providers to communicate risks to patients and provide further assistance. The absence of a coordinated federal response for patient transition highlights a massive gap in regulatory oversight. When a digital health platform collapses under criminal indictment, the subscribers bear the immediate medical consequences. Local clinics face an impossible task of verifying the medical need of prescriptions originally issued by a convicted corporate entity. The Drug Enforcement Administration submitted proposed rules to the White House to restrict the prescribing of controlled substances via telemedicine. These incoming regulations further complicate care continuity for patients seeking new providers.

The corporate structure of Done Global complicated the regulatory response. The company used a professional corporation and management services organization model. The technology company managed the administration while a doctor owned the professional corporation. Regulators questioned whether the management services organization exerted undue influence over clinical decisions. The December 2025 indictment proved that the corporate entity dictated medical practices to maximize subscription revenue. This business model prioritized volume over patient safety. The collapse of this structure proves that the separation between medical practice and corporate administration was entirely fictional.

The corporate indictment serves as a severe warning to private equity and venture capital. Investors who funded the $40 million marketing budget and pushed for rapid subscriber growth may face scrutiny. The legal shield of the management services organization has been pierced. Board members and financial backers can no longer claim ignorance of the clinical operations when the revenue model is fundamentally reliant on illegal drug distribution. Capital markets are rapidly repricing telehealth assets.

Done Global raised capital from three San Francisco Bay Area venture capital firms. These firms manage over $3. 5 billion in combined assets. Craft Ventures provided early funding to the company. The startup used this financial backing to deploy a $40 million marketing budget. This budget funded deceptive advertisements on social media platforms like Facebook and TikTok. The ads targeted drug seeking patients and promised easy access to Adderall. The Department of Justice notes that the company generated over $100 million in revenue by arranging the distribution of 40 million pills. Financial investment in an illicit business enables and increases returns to crime. The investment satisfies upfront costs and funds the growth of the illegal activity.

The December 17, 2025 corporate indictment establishes a new precedent for investor liability. The government treats the management services organization structure as an instrument of fraud. Historically, venture capital firms relied on the management services organization model to separate business operations from clinical care. This separation supposedly protected non physician investors from corporate practice of medicine laws. The Done Global prosecution nullifies this defense. Prosecutors proved that the business entity controlled clinical decisions. The platform paid prescribers based on prescription volume rather than care quality. The software used auto refill technology to dispense stimulants without clinical reassessments. The company mandated psychiatric evaluations lasting under 30 minutes. Patients completed one minute online assessments before receiving same day appointments. Nurse practitioners earned approximately $60, 000 per month for approving prescription refills without meaningful clinical interaction.

The Department of Justice created the Enforcement and Affirmative Litigation Branch in September 2025. This branch broadens liability theories to include reckless disregard. The government builds fraud cases where the algorithm acts as the instrument of the crime. Investors providing capital to expand these algorithms face direct exposure. The legal theory asserts that the management services organization dictated the clinical practices of the professional corporation. The business entity set appointment times and mandated auto refills. The corporate entity circumvented pharmacies that refused to fill prescriptions. Board members and financial backers face questions regarding their knowledge of these operational metrics.

The federal jury in the Northern District of California convicted founder Ruthia He and clinical president David Brody on multiple counts. The charges included conspiracy to distribute controlled substances and conspiracy to commit health care fraud. The prosecution represented a joint effort by the Criminal Division Health Care Fraud Unit and the United States Attorney Office. The December 2025 corporate indictment attaches this exact criminal conduct to the company itself. The Justice Department accuses Done Global of operating a subscription model where individuals paid a monthly fee to receive easy access to Adderall. The company pressured its prescribers to write more prescriptions without a medical purpose. The government views the corporate entity not as a technology provider as a drug distribution network.

The capital markets show an immediate reaction to the November 2025 convictions. Digital mental health investment dropped 82 percent from its 2021 peak. Telehealth companies in the attention deficit hyperactivity disorder sector face new compliance costs. A multi state telehealth platform operating in 20 states faces registration fees exceeding $17, 000 before treating a single patient. The Drug Enforcement Administration requires providers to query state prescription drug monitoring programs for every controlled substance prescription. Providers must conduct mandatory audio video encounters and implement patient identity verification. The new rules eliminate the high volume subscription model.

Venture capital firms require demonstrated clinical rigor before funding digital health startups. Companies implement 60 minute initial assessments rather than the 30 minute maximum mandated by Done Global. Clinics collect collateral data from family members and conduct paid clinical reassessments. The days of automated refill emails and one minute online assessments are over. Investors demand strict compliance with controlled substance advertising regulations. The historic conviction triggers a compliance overhaul that raises costs and intensifies investor scrutiny.

The final chapter for the executives is imminent. Sentencing for Ruthia He and David Brody is scheduled for February 25, 2026. Both face a maximum penalty of 20 years in federal prison. The egregious nature of the conduct, combined with the obstruction of justice and the sheer volume of pills distributed, suggests the prosecution seek sentences near the statutory maximum. The outcome establish the baseline penalty for future telehealth executives convicted of similar crimes.

The federal jury in San Francisco delivered the guilty verdicts on November 19, 2025. The convictions carry severe statutory penalties. Ruthia He faces sentencing on seven distinct counts. David Brody faces sentencing on six counts. The court weigh the sheer volume of the operation. Prosecutors proved the executives arranged the distribution of over 40 million Adderall pills. The enterprise generated over $100 million in revenue. The trial established that the executives intentionally structured the platform to expedite access to stimulants. They limited the medical history available to prescribers. They instructed prescribers to approve medication even when members did not qualify. The jury found these actions constituted a deliberate conspiracy to distribute controlled substances.

The financial damage extends to public and private insurers. The trial revealed the executives submitted false prior authorization requests. These fraudulent claims cost Medicare, Medicaid, and commercial insurers approximately $14 million. The prosecution proved the executives spent $40 million on deceptive social media advertising. They targeted drug seekers to boost subscription numbers. The advertising campaigns directly contradicted the medical need requirement for prescribing Schedule II narcotics. The court heard testimony that the executives ignored warnings about patient overdoses. They continued the conspiracy after learning that members had died from the prescribed medications. This disregard for human life factor heavily into the final sentencing calculation.

The obstruction of justice conviction adds severe weight to the sentencing calculation for Ruthia He. Investigators proved she deleted documents and used encrypted messaging platforms to hide communications. She relocated operations to China to restrict access to personnel and evidence. She transferred $1 million to a shell company in China. She allocated another $1 million for her legal defense prior to her arrest. She researched countries without extradition treaties to the United States. These actions demonstrate a calculated effort to evade law enforcement. The prosecution argued this behavior shows a complete absence of remorse. The judge review these deliberate attempts to derail the grand jury investigation.

The sentencing guidelines require the judge to consider the size of the enterprise. The prosecution established that the executives prioritized profit over patient care. They mandated initial patient encounters last under 30 minutes. They paid prescribers based on the volume of prescriptions. They discouraged follow up appointments by refusing to compensate clinicians for subsequent medical visits. The business model relied entirely on maximizing the number of patients receiving stimulant prescriptions. The executives implemented an automatic refill function. This feature generated automated requests each month to ensure continuous billing without clinical interaction. The court evaluate these structural decisions as aggravating factors during the February 2026 hearing.

The Department of Justice considers this case a landmark victory. The outcome establishes a new precedent for prosecuting digital health companies. The convictions prove that corporate executives cannot hide behind a medical practice to distribute narcotics. The government successfully argued that the executives exercised illegal control over medical decisions. The table details the specific convictions and the maximum statutory penalties for each executive.

The data and claims in this investigation are grounded in verified federal records and court documents.

• Mintz. A of its Kind Telemedicine Criminal Prosecution. July 03, 2024.
• Department of Justice. Digital Health Company and Medical Practice Indicted. December 17, 2025.
• Department of Justice. Founder CEO and Clinical President Arrested. June 13, 2024.
• Fierce Healthcare. Digital health company Done indicted. December 19, 2025.
• Verrill Law. Digital Health Company Executives Convicted. November 24, 2025.
• Ropes and Gray. DOJ Done Global Telehealth Prosecution. January 15, 2026.
• Spodek Law Group. Telemedicine Prescribing and Federal Enforcement. December 14, 2025.
• BH Business. Done Global Arrests Cast A Long Shadow. June 27, 2024.

The Department of Justice executed a targeted enforcement operation against Done Global and its leadership. Federal prosecutors presented evidence detailing a massive operation designed to distribute controlled substances without valid medical purposes. The government proved that the company prioritized subscription revenue over patient safety. Court records confirm the enterprise generated over 100 million dollars in revenue. The operation arranged for the prescription of over 40 million pills of Adderall and other stimulants. The timeline of federal actions reveals a systematic destruction of the corporate structure.

Federal agents arrested founder Ruthia He and clinical president David Brody on June 13, 2024. The arrests marked the criminal drug distribution prosecution involving a digital health platform. A federal jury in San Francisco convicted both executives on November 18, 2025. The jury found He and Brody guilty of conspiracy to distribute controlled substances. They also received convictions for four counts of distribution of controlled substances and one count of conspiracy to commit health care fraud. The jury convicted He of an additional count of conspiracy to obstruct justice. Prosecutors presented evidence showing He attempted to move operations to China to evade federal authorities.

The Department of Justice escalated the enforcement action by indicting the corporate entities on December 17, 2025. A federal grand jury charged Done Global and Mindful Mental Wellness with conspiracy to illegally distribute Adderall. The indictment included four counts of illegal distribution and conspiracy to commit health care fraud. Prosecutors also charged the companies with conspiracy to obstruct justice. Mindful Mental Wellness operated as a Florida medical practice. Done Global incorporated this entity specifically to bypass pharmacies that refused to fill prescriptions from the primary platform. The corporate indictment represents a rare maneuver by federal prosecutors. The government chose to pursue criminal charges against the business entities instead of negotiating a civil settlement.

Financial records presented during the trial quantified the scope of the fraud. The enterprise submitted false prior authorization requests to insurance providers. The company falsely claimed patients met diagnostic criteria for attention deficit hyperactivity disorder. The platform also falsely certified that nonstimulant medications had failed. These deceptive practices caused Medicare, Medicaid, and commercial insurers to pay over 14 million dollars in fraudulent claims. The company spent millions on targeted social media advertisements to attract drug seekers. The business model compensated prescribers based on prescription volume rather than consultation quality. The platform limited initial patient encounters to brief video or audio calls. patients received prescriptions without any direct communication with a medical professional.

The trial exposed internal directives that restricted clinical discretion. Executives imposed strict time limits on patient consultations. The company refused to compensate providers for follow up care. The platform utilized an automatic refill feature to maintain subscription revenue. Providers faced pressure to prescribe stimulants even when medical evidence did not support the decision. The Drug Enforcement Administration and the Department of Health and Human Services Office of Inspector General led the investigation. The agencies documented how the enterprise exploited pandemic era telemedicine rules. The temporary rules allowed providers to prescribe controlled substances without an in person examination. Done Global weaponized these rules to build a lucrative distribution network.

The corporate indictment details the obstruction of justice charges. Done Global executives conspired to alter, destroy, and conceal records after receiving a grand jury subpoena. The company attempted to hide the true nature of its prescribing practices from federal investigators. The Florida shell company, Mindful Mental Wellness, played a central role in the scheme. The enterprise used the Florida entity to disguise the origin of the prescriptions. The government demonstrated that the defendants built a business model based on deception. The executives face a maximum penalty of 20 years in federal prison. The corporate entities face financial penalties equal to twice the gross profits from the illegal distribution. The penalties also include twice the gross loss for the health care fraud conspiracy.

The convictions and subsequent corporate indictment establish a new precedent for federal enforcement. The Department of Justice demonstrated the capability to prosecute digital health platforms for drug distribution. The government proved that corporate policies can constitute criminal conspiracy when they override independent medical judgment. The evidence confirmed that the enterprise operated as a sophisticated drug distribution ring disguised as a medical clinic. The federal records validate every claim regarding the operational methods and financial metrics of the organization. The trial documents provide a complete accounting of the fraudulent practices. The government successfully terminated the operation and secured convictions against the primary architects of the scheme.